The charity’s commercial arm saw the amount of money from both internal and external sources invested in its spinouts more than double in the last year.
The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.
We cover the latest cancer research, including that funded by the charity. We also highlight other relevant material, debunk myths and media scares, and provide links to other helpful resources.
Text from Cancer Research UK's News site by Cancer Research UK, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License.